ED
Exane Derivatives’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Hold |
0
| – | – | – | 598 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 559 |
|
|
2017
Q3 | – | Sell |
-23,154
| Closed | -$789K | – | 534 |
|
|
2017
Q2 | $789K | Sell |
23,154
-58,346
| -72% | -$1.99M | 0.17% | 90 |
|
|
2017
Q1 | $2.54M | Sell |
81,500
-73,646
| -47% | -$2.29M | 0.57% | 53 |
|
|
2016
Q4 | $4.24M | Sell |
155,146
-90,130
| -37% | -$2.46M | 0.84% | 16 |
|
|
2016
Q3 | $8.06M | Buy |
+245,276
| New | +$8.06M | 1.21% | 24 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 554 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 470 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 478 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 471 |
|
|
2015
Q1 | – | Sell |
-1,597
| Closed | -$112K | – | 468 |
|
|
2014
Q4 | $112K | Buy |
+1,597
| New | +$112K | 0.02% | 243 |
|